Coronavirus Treatment Drugs Market, by Drug Class, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

The coronavirus treatment drugs comprises therapeutics which are used for treatment of the novel coronavirus. There are various drug classes such as corticosteroids, anti-viral, monoclonal antibodies, Kinase inhibitors which can be used for treatment of the coronavirus. The coronavirus is generally treated depending on severity of symptoms such as severe, moderate and mild. The common symptoms of coronavirus are cold, fever, breathlessness, headache, and stomach pain.

Market Dynamics

Key players are focusing on obtaining product approvals in order to strengthen their position in the global coronavirus treatment drugs market. For instance, in June 2020, Glenmark Pharmaceuticals Limited, a pharmaceutical company in India, launched the first orally administered tablet, Fabiflu, for the treatment of patients suffering from mild and moderate symptoms of COVID-19. Fabiflu is available as a 200 mg tablet, has been priced at US$ 1 per tablet. A strip of 34 tablets will cost US$ 47.55 to the patients in India.

Furthermore, key companies are focusing on inorganic strategies such agreements in order to strengthen their position in the global coronavirus treatments drugs market. For instance, in September 2020, Dr Reddy's Laboratories, an Indian pharmaceutical company, announced the launch of Remdesivir under the brand name, Redyx, for the Indian market. The launch of Redyx for treatment for COVID-19 is because of licensing agreement of Dr Reddy Laboratories with Gilead Sciences Inc. which grants Dr Reddy's Laboratories the right to register, manufacture and sell Remdesivir, as a potential treatment for COVID-19 in 127 countries including India.

Key features of the study:

This report studies the current scenario as well as the future potential of the global coronavirus treatment drugs market. The market for coronavirus treatment drugs is segmented on the basis of drug class, route of administration, distribution channel, and region.
This report provides in-depth analysis of the global coronavirus treatment drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
It profiles leading players in the global coronavirus treatment drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
The global coronavirus treatment drugs market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global coronavirus treatment drugs market.

Detailed Segmentation:

Global Coronavirus Treatment Drugs Market, By Drug Class:
- Corticosteroids
- Anti-viral
- Monoclonal Antibodies
- Kinase Inhibitors
- Others
Global Coronavirus Treatment Drugs Market, By Route of Administration:
- Oral
- Intravenous
Global Coronavirus Treatment Drugs Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Coronavirus Treatment Drugs Market, By Region:
- North America
  - By Drug Class:
  - Corticosteroids
  - Anti-viral
  - Monoclonal Antibodies
  - Kinase Inhibitors
  - By Route of Administration:
  - Oral
  - Intravenous
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - U.S.
  - Canada
- Latin America
  - By Drug Class:
  - Corticosteroids
  - Anti-viral
  - Monoclonal Antibodies
  - Kinase Inhibitors
  - By Route of Administration:
  - Oral
  - Intravenous
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Drug Class:
  - Corticosteroids
  - Anti-viral
  - Monoclonal Antibodies
  - Kinase Inhibitors
  - By Route of Administration:
  - Oral
  - Intravenous
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Drug Class:
  - Corticosteroids
  - Anti-viral
  - Monoclonal Antibodies
  - Kinase Inhibitors
  - By Route of Administration:
  - Oral
  - Intravenous
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country:
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Drug Class:
  - Corticosteroids
  - Anti-viral
  - Monoclonal Antibodies
  - Kinase Inhibitors
  - By Route of Administration:
  - Oral
  - Intravenous
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country/Region:
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Drug Class:
  - Corticosteroids
  - Anti-viral
  - Monoclonal Antibodies
  - Kinase Inhibitors
  - By Route of Administration:
  - Oral
  - Intravenous
  - By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Serum Institute of India*
  - Company Overview
  - Material Portfolio
  - Financial Performance
  - Key Highlights
  - Market Strategies
- Pfizer Inc.
- AstraZeneca plc.
- Bharat Biotech International Limited
- Cadila Healthcare Limited
- Johnson & Johnson
- Moderna
- GlaxoSmithKline plc.
- CanSino Biologics
- Sinovac Biotech
- Novavax, Inc.
- Glenmark Pharmaceuticals Limited
- Dr. Reddy's Laboratories
- Merck & Co., Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI4312

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug Class
Market Snapshot, By Route of Administration
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Drivers
Restraints
Opportunities
Impact Analysis
Key Developments
New Product Launches/Approvals
Merger-Acquisition Scenario
Regulatory Scenario
Pipeline Analysis
Epidemiology
PEST Analysis
Reimbursement

4. Global Coronavirus Treatment Drugs Market - Impact of COVID-19 Pandemic

Government Initiatives To Combat COVID-19
Therapeutic Management of COVID-19 Patients

5. Global Coronavirus Treatment Drugs Market, By Drug Class, 2017 - 2028 (US$ Mn)

Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Anti-viral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Kinase Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Coronavirus Treatment Drugs Market, By Route of Administration, 2017 - 2028 (US$ Mn)

Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Coronavirus Treatment Drugs Market, By Distribution Channel, 2017 - 2028 (US$ Mn)

Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

8. Global Coronavirus Treatment Drugs Market, By Region, 2017 - 2028 (US$ Mn)

Introduction
Market Share Analysis, By Country, 2022 and 2028 (%)
Y-o-Y Growth Analysis, For Countries, 2017 - 2028
North America
Introduction
Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- U.S.
- Canada
Latin America
Introduction
Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
- South Africa
- Central Africa
- North Africa

9. Competitive Landscape

Company Profiles
- Serum Institute of India
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AstraZeneca plc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bharat Biotech International Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cadila Healthcare Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Moderna
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- CanSino Biologics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sinovac Biotech
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novavax, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Glenmark Pharmaceuticals Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dr. Reddy's Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck & Co., Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies

Coronavirus Treatment Drugs Market, by Drug Class, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028